Clinical trials recruiting in Changwon, South Korea
7
Recruiting trials
15
Conditions
Phase breakdown
Phase 3 2Phase 4 1Not applicable 4
Conditions recruiting in Changwon, South Korea
Recruiting trials in Changwon, South Korea
- A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
- A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
- ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
- PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomized Controlled Trial
- Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
- Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction
- Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
Common questions
How many clinical trials are recruiting in Changwon, South Korea?
7 recruiting trials have at least one study site in Changwon, South Korea.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.